Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Yellow Fever Vaccine Market Size Outlook: How Fast Will Revenue Grow Through 2030?
The market for yellow fever vaccines has experienced consistent expansion over the past few years. Projections indicate an increase from $4.74 billion in 2025 to $4.97 billion in 2026, reflecting a compound annual growth rate (CAGR) of 4.8%. This historical growth has been driven by factors such as repeated yellow fever outbreaks, compulsory government vaccination policies, proven vaccine effectiveness, travel regulations imposed by international authorities, and various public health programs.
The yellow fever vaccine market is projected to experience consistent expansion over the coming years, reaching an estimated value of $5.88 billion by 2030, with a compound annual growth rate (CAGR) of 4.3%. This anticipated growth during the forecast period is driven by factors such as the climate-induced spread of mosquitoes, a rise in international travel, improvements in vaccination infrastructure, increased financial support for disease prevention initiatives, and enhanced readiness for outbreaks. Key trends shaping this period include the broadening of routine immunization programs, heightened demand from global travelers, more frequent government-led vaccination drives, a shift toward single-dose vaccine options, and a concentrated effort on preventing diseases in endemic regions.
Download A Free Sample Report For Comprehensive Market Insights:
Yellow Fever Vaccine Market Expansion Drivers: What Is Shaping Future Growth?
The growth of the yellow fever vaccine market is anticipated to be driven by a rise in international travel moving forward. This type of travel involves people crossing national borders for activities like tourism, business, or personal reasons. An increase in international travel is being seen due to heightened global mobility, supported by economic recovery and the relaxation of pandemic-related restrictions. By offering necessary or suggested immunizations for entry into areas where yellow fever is present, the vaccine market serves the needs of travelers. As an example, data from the World Tourism Organization (UNWTO) in January 2024 reveals that global international tourist arrivals hit 1.286 billion in 2023, compared to 0.96 billion in 2022, marking a year-on-year rise of 0.326 billion tourists. Consequently, the expansion of the yellow fever vaccine market is fueled by growing international travel.
Yellow Fever Vaccine Market Segmentation And Category Breakdown
The yellow fever vaccine market covered in this report is segmented –
1) By Product: Powder, Liquid
2) By Application: Routine Immunization, Travelers, Other Applications
3) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users
Subsegments:
1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution
2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes
Yellow Fever Vaccine Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Major players in the yellow fever vaccine industry are placing greater emphasis on creating novel solutions, including T-cell adaptive booster vaccines, to strengthen long-lasting immunity, boost vaccine effectiveness, and overcome the drawbacks of conventional live-attenuated vaccines. These T-cell adaptive booster vaccines are formulated to reinforce the immune system by particularly augmenting T-cell responses, enabling the body to detect and combat infections more efficiently than standard antibody-centric vaccines. As an example, in April 2025, the All India Institute of Medical Sciences, a healthcare facility based in India, introduced the Yellow Fever Vaccination service to shield travelers from the mosquito-transmitted viral disease and provide the globally recognized vaccination certificate. This effort is designed to improve vaccine availability within Telangana, thereby minimizing the necessity for extended travel to other permitted centers. Moreover, the program complies with international health standards by guaranteeing safe vaccine delivery under medical oversight, especially for those with medical contraindications.
Yellow Fever Vaccine Market Competitive Analysis Of Major Industry Participants
Major companies operating in the yellow fever vaccine market are Sanofi S.A., Bio-Manguinhos, Institut Pasteur de Dakar, Instituto Butantan, Bio Farma, Biological E. Limited, Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products, Merck & Co. Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Lonza Group AG, WuXi Biologics, Ology Bioservices, Valneva SE, Bavarian Nordic A/S, Panacea Biotec Ltd., Biovac, Novavax Inc., PnuVax Incorporated
Access The Complete Yellow Fever Vaccine Market Report:
Yellow Fever Vaccine Market Largest Region By Revenue And Market Share
North America was the largest region in the yellow fever vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model